Suzetrigine
First new kind of non-opioid painkiller in decades.
- Starts working
- Varies
- Half-life
- —
- In use since
- 2025
- Pregnancy
- Use with caution
Overview
Suzetrigine is a non-opioid tablet for short-term moderate to severe pain, approved in the US in January 2025. It blocks a sodium channel found almost only on pain-sensing nerves, so it doesn't cause the euphoria, breathing problems or addiction of opioids.
Conditions it's used for
How it works
Stops pain nerves outside the brain from firing, without affecting the brain itself.
Suzetrigine belongs to the NaV1.8 sodium channel blockers. How NaV1.8 sodium channel blockers work: block a sodium channel found almost only on pain-sensing nerves outside the brain, stopping pain signals at the source without the reward or breathing effects of opioids.
Uses
- Moderate to severe acute pain in adults (e.g. after surgery)
Available as: tablet.
Typical dose
- Adults
- 100 mg first dose on an empty stomach, then 50 mg every 12 hours, for up to 14 days.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Itching
- Muscle spasms
- Rash
- Raised creatine kinase on blood tests
Serious — get medical help
Uncommon, but need prompt attention
- Severe reactions are uncommon; long-term safety is still being studied
Warnings
- Avoid grapefruit
- Not with strong CYP3A4 inhibitors
- May reduce the effect of hormonal contraceptives — use extra protection
Interactions
- Clarithromycin, itraconazole, ritonavir — contraindicated
- Rifampicin, carbamazepine — reduce its effect
- Hormonal contraceptives — less effective
Other medicines in the atlas that need care with Suzetrigine, grouped by the reason:
Dangerous rise in drug levelsMajorWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more
A strong CYP3A4 inhibitor blocks breakdown of a drug where higher levels are hazardous (e.g. simvastatin — muscle breakdown; colchicine — fatal toxicity; tacrolimus — kidney damage; fentanyl or midazolam — breathing suppression).
What's usually done: Usually contraindicated or needs a planned pause or major dose change. Always check with a pharmacist.
Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more
Enzyme induction lowers levels of this medicine, which may stop it working.
What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.
Pregnancy and breastfeeding
Use with caution
Too little data; use only if benefits outweigh unknown risks.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Journavx
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
History
2025
US FDA approves Journavx (Vertex) on 30 January — the first new class of acute pain medicine in over 20 years.
The NaV1.8 target was found by studying the biology of people born unable to feel pain or with extreme pain disorders.
In trials after bunion and tummy-tuck surgery it beat placebo but was not clearly better than hydrocodone with paracetamol.
Common questions
Is it addictive?
It doesn't act on reward pathways in the brain and showed no signs of misuse potential in studies, so it is not a controlled drug.
Do I need a prescription for Suzetrigine?
Yes — Suzetrigine is prescription-only in most countries.
Can I take Suzetrigine during pregnancy?
Use with caution. Too little data; use only if benefits outweigh unknown risks. Always check with a doctor or midwife.
Related medicines
Sources and official information
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.